UK Markets closed

Intercept Pharmaceuticals, Inc. (ICPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
18.26+0.32 (+1.78%)
As of 01:42PM EST. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts14151014
Avg. Estimate4.610.034.71-3.48
Low estimate-1.19-2.15-3.19-8.83
High estimate11.689.1610.81.45
Year ago EPS-0.11-1.23-2.874.71
Revenue estimateCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
No. of analysts15161016
Avg. Estimate74.07M76.7M312.94M313.76M
Low estimate69M63.45M299.74M233.01M
High estimate82.5M92.4M335.28M412M
Year ago sales92.83M92.4M363.47M312.94M
Sales growth (year/est)-20.20%-17.00%-13.90%0.30%
Earnings history29/09/202130/12/202130/03/202229/06/2022
Est. EPS-1.09-1.1-0.9-0.49
Actual EPS-0.11-1.23-0.58-0.25
Difference0.98-0.130.320.24
Surprise %89.90%-11.80%35.60%49.00%
EPS trendCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Current estimate4.610.034.71-3.48
7 days ago4.610.034.1-3.48
30 days ago5.56-0.814.46-3.24
60 days ago5.19-0.814.96-2.76
90 days ago3.83-0.642.92-3.18
EPS revisionsCurrent qtr. (Sep 2022)Next qtr. (Dec 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days1525
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesICPTIndustrySector(s)S&P 500
Current qtr.4,290.90%N/AN/AN/A
Next qtr.102.40%N/AN/AN/A
Current year264.10%N/AN/AN/A
Next year-173.90%N/AN/AN/A
Next 5 years (per annum)-8.89%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A